Ottawa’s life sciences sector has emerged into the global market as a center of discovery, development and commercialization. Headquarters to Canada’s federal government, including departments directly responsible for health regulation, protection, promotion and research funding, the city provides an ideal base for innovation support. With a strong combination of academic research, centers of excellences, access to world leading hospitals and industry, the nation’s capital provides a lucrative environment for leading-edge products, technologies and innovations.
Ottawa research hospitals provide a strong base for research and development (R&D) in the region. In fact, out of forty top Canadian hospital research institutions, five are in Ottawa. Combined, their research spending reached $180 Million for 2015. Additionally,the University of Ottawa Heart Institute (OHRI) is Canada’s largest cardiovascular research centre and ranks in the top 3% of worldwide research institutions based on the quality and impact of their scientific publications. Continuing Ottawa’s long-standing history of innovation and entrepreneurship, the Ottawa Hospital has produced 7 spin-off companies and 6 world leading clinical trials from 2015-2016.
With world-leading medical discoveries, Ottawa has become home to two national life science Networks of Centres of Excellence (NCE) all active in supporting large-scale, academic-led research programs to accelerate R&D and commercialization. They include:
- The Stem Cell Network, Canada’s premier research organization dedicated to enabling the translation of stem cell research into clinical applications, commercial products and public policy.
- Biotherapeutics for Cancer Treatment (BioCanRx), pan-Canadian network of expertise and infrastructure for the development, manufacture and clinical testing of new personalized biotherapeutics that hold the promise of being more effective, affordable and safe than conventional cancer therapies.